About
Treg Cell Therapy for Autoimmune Diseases
Areas of Focus
Categories
Stem Cell & Cellular TherapyBiotech
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
6
As Collaborator
5
Total Enrollment
345
By Phase
PHASE1/PHASE2: 5PHASE2: 2PHASE2/PHASE3: 1PHASE1: 3
By Status
ACTIVE_NOT_RECRUITING: 5RECRUITING: 4NOT_YET_RECRUITING: 2
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06590545Collaborator
Anti-CD 19 CAR-T Cell Therapy in Patients with ANCA Vasculitis
PHASE1/PHASE2Not yet recruiting
8 participants
Started: Jan 31, 2025 · Completed: Jul 31, 2027
NCT06475495Collaborator
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
PHASE1/PHASE2Not yet recruiting
13 participants
Started: Nov 30, 2024 · Completed: Mar 31, 2027
NCT06588491Lead Sponsor
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome
PHASE2Recruiting
25 participants
Started: Sep 25, 2024 · Completed: Dec 31, 2026
NCT06384976Lead Sponsor
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
PHASE2Active, not recruiting
120 participants
Started: Sep 20, 2024 · Completed: Jan 31, 2029
NCT06193889Lead Sponsor
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
PHASE2/PHASE3Recruiting
66 participants
Started: Aug 28, 2024 · Completed: Sep 30, 2028
Locations (1)
Headquarters
Emeryville, CA, United States
Map
Loading map...